Trade JAZZ anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Jazz Pharmaceuticals plc Common Stock (Ireland) (JAZZ) is trading at US$246.19, down 1.96% today as of Aug 28, 13:03 EDT. The company has a market capitalisation of US$16.51B. Over the past 52 weeks, JAZZ has traded between US$123.88 and US$266.38. On Syfe you can trade JAZZ with $0 commission and add it to your watchlist.
| Previous close | US$251.10 |
|---|---|
| Market cap | US$16.51B |
| P/E ratio | 9.61 |
| 52-week range | US$123.88 – US$266.38 |
| Volume | 4.77M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Jazz Pharmaceuticals plc Common Stock (Ireland)
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
Year: 2007
Jazz Pharmaceuticals plc Common Stock (Ireland) (JAZZ) stock is trading at US$246.19, -1.96% from the previous close of US$251.10.
The market cap for Jazz Pharmaceuticals plc Common Stock (Ireland) (JAZZ) stock is approximately US$16.51B.
The price-to-earnings ratio for Jazz Pharmaceuticals plc Common Stock (Ireland) (JAZZ) is 9.61, based on the latest reported earnings.
The 52-week high for Jazz Pharmaceuticals plc Common Stock (Ireland) (JAZZ) stock is US$266.38.
The 52-week low for Jazz Pharmaceuticals plc Common Stock (Ireland) (JAZZ) stock is US$123.88.
Jazz Pharmaceuticals plc Common Stock (Ireland) (JAZZ) does not currently pay a dividend.
Stay on top of JAZZ
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
